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ABSTRACT
Background. Perioperative complications following
inguinal lymphadenectomy, including seroma formation,
are frequent. We have employed a 2-layer negative pres-
sure wound therapy (2-LNPWT) as a method to reduce
seroma rate and perioperative complications. We present
the outcome of our initial experience with 2-LNPWT and
compare the outcomes of its use with traditional closed
suction drains (CSDs).
Materials and methods. A non-randomised retrospective
case–control series was analysed. Surgeons performing
inguinal lymphadenectomy for metastatic cutaneous mel-
anoma utilised either the 2-LNPWT therapy or traditional
CSDs according to their practice preference.
Results. The study included 111 patients. The cohorts
were well matched for gender, disease burden, body mass
index and comorbidities. The 2-LNPWT technique was
associated with significantly better postoperative outcomes
than CSD, in terms of incidence of seroma formation
(26.9% vs 49.4%; p\ 0.03), period of drainage (15 days
vs 20 days; p = 0.005) and return to theatre rate (0% vs
15.3%; p = 0.03). The overall seroma rate was 44.1%. The
only significant association with seroma initiation was the
type of drainage system used (2-LNPWT 31.2% vs CSD
58.3%; p\ 0.03; OR 3.0). The method of drainage did not
alter the course of an established seroma. There was no
significant difference in overall or disease-specific survival
detected between the 2 groups.
Conclusion. This retrospective non-randomised case con-
trol study has demonstrated the safe use of a novel
application of negative pressure wound therapy that sig-
nificantly reduced the incidence of seroma formation and
postoperative complication rate for inguinal lym-
phadenectomy for melanoma.
Inguinal lymphadenectomy is the current standard of
care in the management of macroscopic lymph node
metastasis. Postoperative complications following inguinal
dissection commonly include seromas, wound infection,
impaired wound healing, cellulitis and skin necrosis.1,2
Seroma formation accounts for 32–80% of presentations
postoperatively.2 These patients routinely return to outpa-
tient clinics for aspiration and resolution of the problem is
often protracted. As a direct result of the repeated seroma
aspirations and drainage, subsequent complications such as
infection may follow. This often leads to unscheduled
returns to theatre for a further surgical procedure and in
turn could result in suboptimal rehabilitation and potential
disability.
Negative pressure wound therapy (NPWT) was origi-
nally indicated for complex wounds to promote healing. Its
use has become widespread in reconstructive, oncological
and emergency surgery to initiate wound healing, to reduce
infection rates and to stabilise challenging wounds.3–7 The
underlying mechanism of action is to increase the vascu-
larity of the wound bed by promoting granulation tissue
formation. The direct action of the negative pressure within
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the dressing also serves to remove excess fluid and reduce
wound oedema. More recently, the indications for NPWT
have expanded to include the management of high-output
exudate and seromas by employing it as an alternative
method to closed suction draining.8
In our unit, a modified two-layer negative pressure
wound therapy (2-LNPWT) dressing in combination with a
standard negative pressure dressing system [Renasys Go,
Smith & Nephew, UK] has routinely been employed as a
standard of care to manage inguinal lymphadenectomy
wounds postoperatively by the senior author (MM). The
rationale for employing the 2-LNPWT technique is that it
acts as a traditional closed-suction drainage (CSD) system
whilst simultaneously applying continuous external com-
pression to the skin and the wound cavity deep to it. The
CSD was employed as a standard of care by the other
senior author (MH). We undertook a retrospective non-
randomised case–control study over a 4-year period to
investigate whether there was any evidence for a periop-
erative therapeutic advantage of 2-LNPWT over traditional
closed suction drainage.
METHODS AND MATERIALS
This case-series review was registered as an audit at the
Norfolk & Norwich University Hospital (Audit Reference
Number: Plas-15-16-003, registered November 2015). All
patients were treated at a single tertiary-referral university
hospital cancer centre and the patients were identified from
our prospectively maintained melanoma database. Further
surgical and follow-up data were obtained from the
patients’ electronic records and case written notes. Missing
data held by other centres were requested and completed
wherever achievable. Data were collected on patient
demographics and diagnosis, in addition to admission and
readmission data, seroma formation rates, total number of
days with drain, return to theatre rate and other standard-
ised complications as collected for our monthly morbidity
and mortality meetings. Examples of the latter included
postoperative wound infection, haematoma and wound
dehiscence. Disease-specific and overall survival outcomes
were obtained from the prospective and contemporaneous
melanoma database.
Statistical collection was performed using Excel. Non-
parametric statistical tests such as Fisher’s exact test and
the Mann–Whitney U test were utilised and an alpha of
0.05 was used as the cut-off to determine statistical sig-
nificance. For the purpose of this study, a seroma was
defined as a symptomatic postoperative collection of lym-
phatic fluid at the lymphadenectomy site, following
removal of the drain, that required an intervention (usually
aspiration) to remove or reduce it. A perioperative
complication was defined as any untoward event that
started within 31 days of lymphadenectomy. The Clavien
Dindo system9 was used to classify complication severity.
Lymphoedema rates were specifically not measured in this
study, due to the unpredictable onset postoperatively of the
condition.
OPERATIVE TECHNIQUE
Patients were identified as being suitable for lym-
phadenectomy and the procedure was performed after
discussion within the multidisciplinary team meeting. The
patients were assessed and appropriately counselled by
their surgeon, prior to embarking on surgery. The operative
technique consisted of standardised open lymphadenec-
tomy which included an oblique elliptical incision
extending from the groin crease infero-medially to the apex
of the femoral triangle. The extent of the skin excision was
arbitrarily determined intra-operatively by the surgeon
depending on the available laxity of the skin overlying the
femoral triangle. Skin flaps were raised at the level of the
superficial fascia to the extent of the boundaries of the
femoral triangle. Inguinal lymph nodes were removed en
bloc, incorporating the long saphenous vein in the speci-
men. Large, visible lymphatics were ligated en masse with
vicryl sutures at the proximal and distal limits of the
femoral triangle. A sartorius muscle turn-over flap was not
performed.
A 2-LNPWT system was chosen by one surgeon (MM)
on the basis of the perceived ability of the patient to be able
to safely mobilise with the dressing and access outpatient
care readily in the postoperative period. Where these 2
criteria were not met in the opinion of that surgeon, CSD
was used instead. The other surgeon (MH) utilised only
CSD. Where a CSD system was employed, a drain was
inserted prior to wound closure (15 Fr Blake drain: Ethicon
Inc, Johnson & Johnson) exiting in the vicinity of the
anterolateral mid-thigh where it was firmly secured to the
patient with sutures before connecting to a vacuum drai-
nage bottle. The sequence of images in Fig. 1 demonstrates
the deployment of the alternative 2-LNPWT dressing.
Essentially, the wound is sutured in layers, save for the
cFIG. 1 Stepwise demonstration of application of 2-LNPWT dressing
after inguinal dissection. a Wound closure leaving distal and proximal
ends open approx 1–2 cm. b Foam wick with silicone dressing to
prevent granulation tissue formation. c Wicks inserted in each wound
opening. d Adherent film applied over wound to create a seal and
perforated over each foam wick. e 2nd layer of foam cut to the
dimensions of the dissection cavity. f 2nd layer of adherent film over
foam and perforated in centre. g Connection tubing attached over
perforation running laterally to pump (Note: separate incison in left
iliac fossa for pelvic dissection)
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terminal 1–2 cm at each end (Fig. 1a). Foam wicks are
inserted into the residual defect and covered with a non-
adherent silicone dressing, which prevents premature clo-
sure and excess granulation tissue formation at the exit
sites (Fig. 1b–d). An occlusive dressing is placed over the
wound and is perforated over the foam wicks. A second,
separate layer of foam, wide enough to cover the extent of
the underlying dissection cavity, is placed over the wound
and this is sealed with a second occlusive dressing
(Fig. 1e). The occlusive dressing is then perforated
(Fig. 1f) to allow placement of the connecting tubing
(Fig. 1g) and connected to the suction unit. The unit was
invariably set to 75 mmHg of continuous negative
pressure.
Postoperatively, patients are mobilised the day after
surgery and are discharged home the following day. The
standard protocol for the management of the CSD system
was to continue drainage until the daily output total was
less than 30 ml in a 24-h period. CSDs were taken off
suction at 5 days and continued with ‘free’ gravitational
drainage until removal. The philosophy behind this proto-
col is to prevent propagation of the lymphorrhoea at the
drain site by the negative pressure in the cavity. In the case
of the 2-LNPWT system, the entire dressings were changed
every 3–4 days by the plastic surgery nurses in the dress-
ings clinic until the canister demonstrated little or no
drainage over a 24-h period. This was a clinical judgement
based upon the volume of altered silica gel compound in
the canister at review. In all cases, the drainage period
recorded was the number of days calculated from the date
of the surgery to the date of removal of the drainage
system.
RESULTS
A total of 133 patients were identified retrospectively
over a 5-year period between January 2010 and November
2015. Complete datasets were available for analysis on 111
patients (83.5% of cohort). There were 39 males and 72
females (35.1% vs 64.9%). The median age was 66.0 years
[IQR 56.0–75.0]. There were 40 smokers (36.0%) and the
median BMI was 26.1. Fifty patients (45.0%) underwent
surgery for a positive sentinel biopsy compared to 61
(55.0%) who underwent a therapeutic procedure for pal-
pable disease. Approximately half the patients (51.3%)
underwent a simultaneous pelvic dissection. The median
N-ratio was 0.17 [IQR 0.10–0.27] and extracapsular spread
was identified in the resection specimen in over a fifth of
patients (22.5%). The overall return to theatre rate was
11.7% (13 patients). Postoperatively the drains remained
in situ for a median of 17 days [IQR 12.8–25.0 days].
Seroma data were missing for 17 patients (15.3%) but the
overall incidence of seroma formation was 52.9% (49/94
patients). The median total seroma volume was 620 ml.
The overall complication rate was 35.1% (39 participants),
though the majority of these were trivial, Grade I episodes
(59.0%).
Table 1 outlines the comparison of patient demograph-
ics, tumour characteristics and burden, pathology and
perioperative course between the 2-LNPWT and CSD
groups. The patients in the 2-LNPWT were significantly
younger (57.5 vs 69.0 years; p\ 0.007), otherwise the
groups were well-matched for gender, ASA grade, smoking
status and BMI. Similarly, both groups were well-matched
for burden of disease, indications for surgery, extent of
surgery and risk for regional recurrence (extracapsular
spread). Whilst there was no significant difference in
complication rate, severity of complications or seroma
volume drained between the two groups, there was a sig-
nificantly reduced seroma rate (29.6% vs 49.4%; p\ 0.03)
and a significantly reduced return to theatre rate (0% vs
15.3%; p = 0.03) in the 2-LNPWT group. The median
period of drainage was significantly reduced by almost
1 week in the 2-LNPWT group (15 vs 20 days; p = 0.005)
compared to the CSD group. There was no significant
difference in overall or disease-specific survival detected
between the 2 groups. The median survival overall and
disease-specific survival was 37 months and 56 months,
respectively in the CSD group, and not reached in the
2-LNPWT group. The median disease-free interval was
16.5 months in the 2-LNPWT group and 30.5 months in
the CSD group. This disease-free survival difference did
not reach statistical significance (p = 0.1) and multivariate
analysis with Cox’s proportional hazards method identified
a number of positive nodes as the only significant inde-
pendent predictor of relapse (p = 0.01; HR = 1.17
[1.07–1.28]). There were only two instances of in-field
nodal relapse, both in the CSD group.
Table 2 outlines the comparison between the groups of
patients who developed a seroma (n = 49, 52.9%) and
those who did not (n = 45, 47.9%). There were no signif-
icant risk factors identified for the development of seroma
in terms of patient demographics, comorbidities or tumour
burden. Similarly, tumour burden, extent of surgery, and
complication rate were not associated with seroma forma-
tion. CSD was associated with a significantly increased risk
of seroma formation in our cohort (31.2% vs 58.3%; odds
ratio = 3.0 [95% CIs 1.1–8.3], p\ 0.03). The method of
drainage used was the only significant risk factor associ-
ated with the development of postoperative seroma
identified in our cohort.
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TABLE 1 Comparison of patient demographics, tumour characteristics and burden, pathology and perioperative course between 2-LNPWT and
CSD groups
Variable 2-LNPWT
n = 26 (%)
CSD




Male 6 (23.0) 33 (38.8) 39 (35.1) ns
Female 20 (76.9) 52 (61.2) 72 (64.9)
Age
Median 57.5 69.0 66 p\ 0.007
IQR [46.8–67.8] [59.0–76] [56.0–75.0]
ASA grade
0 2 (7.7) 6 (7.0) 8 (7.2) ns
1 5 (19.2) 14 (16.5) 19 (17.1)
2 15 (57.7) 53 (62.4) 68 (61.3)
3 4 (15.4) 12 (14.1) 16 (14.4)
Smoker
Yes 7 (26.9) 33 (38.8) 40 (36.0) ns
No 19 (73.0) 52 (61.2) 71 (64.0)
BMI
Median 27.0 25.8 26.1 ns
IQR [25.0–30.8] [23.8–29.6] [24.2–30.0]
Tumour burden and pathology
Indication for surgery
Completion lymph node dissection 16 (61.5) 34 (40.0) 50 (45.0) ns
Therapeutic 10 (38.5) 51 (60.0) 61(55.0)
Pelvic dissection
Yes 9 (34.6) 48 (56.5) 57 (51.3) ns
No 17 (65.4) 37 (43.5) 54 (48.7)
N-ratio
Median 0.13 0.17 0.15 ns
IQR [0.11–0.2] [0.09–0.29] [0.10–0.27]
Extracapsular spread
Absent 15 (57.7) 37 (43.5) 52 (46.8) ns
Present 4 (15.4) 21 (24.7) 25 (22.5)
Not stated 7 (26.9) 27 (31.8) 34 (30.6)
Perioperative course
Length of stay (days)
Median 8 8 8 ns
IQR [5.3–10.5] [6.0–11.0] [6.0–11.0]
Return to theatre
No 26 (100.0) 72 (84.7) 98 (88.3) p = 0.03





No 15 (57.7) 30 (35.3) 45 (40.5) p\ 0.03
Yes 7 (26.9) 42 (49.4) 49 (44.1) OR: 3.0
Not stated 4 (15.4) 13 (15.3) 17 (15.3) (1.1-8.3)
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DISCUSSION
It is generally acknowledged that inguinal lym-
phadenectomy is a standard procedure in the surgical
oncology armamentarium that has a disproportionately
high complication rate.2 Whilst the complications are
generally non-life threatening and localised to the site of
operation, they are often protracted and have a substantial
impact on the patients’ quality of life. One of the most
common postoperative complications in the perioperative
period is seroma.1,10,11 There have been multiple studies
that have investigated interventions designed to either
reduce the incidence or reduce the extent of the problem
once it has become established.12–15 A recent systematic
review by the Cochrane Group11 identified a lack of any
useful data and concluded that, ‘‘…there is a need for high
quality RCTs to guide clinical practice in this under-
researched area.’’ Unfortunately, there have been no stud-
ies to date that have demonstrated a reliable method to
reduce the incidence of seroma.
This retrospective cohort study has attempted to com-
pare both the incidence of postoperative seroma formation
and the duration of seroma drainage following inguinal
lymphadenectomy for metastatic melanoma between two
methods of wound drainage. Whilst there was no ran-
domisation of the cohort between the two systems, the
cohorts were well matched in terms of demographics,
disease burden and extent of surgery. There was a signifi-
cant bias towards younger patients for the 2-LNPWT
system, which probably reflects the perceived ability of the
patient by the treating clinician to manage the bulkier
vacuum pump system and/or the opportunity to return to




n = 26 (%)
CSD
n = 85 (%)
Total Significance
Period with drain (days)
Median 15 20 17 p = 0.005
IQR [9.5–15.8] [15.8–26.3] [12.8–25.0]
Seroma aspirations (n)
Median 1 0 0 ns
IQR [0–3] [0–3] [0–3]
Total seroma volume (ml)
Median 525 690 620 ns
Complication (n)
No 19 (73.0) 53 (62.3) 72 (64.9) ns
Yes 7 (26.9) 32 (37.6) 39 (35.1)
Complication subtype
Haematoma 0 2 (6.3) 2 (5.1)
Thromboembolism 1 (14.3) 0 1 (2.6)
Post-op confusion 0 1 (3.1) 1 (2.6)
Neuropraxia 1 (14.3) 0 1 (2.6)
Wound dehiscence 0 7 (21.9) 7 (17.9) ns
Wound infection 5 (71.4) 22 (68.8) 27 (69.2)
Complication severitya
0 19 (73.0) 53 (62.4) 72 (64.9) ns
I 5 (19.2) 18 (21.2) 23 (20.7)
II 1 (3.8) 2 (2.4) 3 (2.7)
IIIA 1 (3.8) 1 (1.1) 2 (2.7)
IIIB 0 (0.0) 11 (12.9) 11 (9.9)
Survival (median, months)
Overall survival Not reached 37 38 ns
Disease-specific survival Not reached 56 56 ns
aThe Clavien–Dindo9 classification of surgical complications
Negative Pressure Therapy and Groin Dissection 3697
TABLE 2 Comparison of patient demographics, tumour characteristics and burden, pathology and perioperative course between the seroma
formation and no seroma formation groups
Variable No seroma formation
n = 45 (%)
Seroma formation




Male 16 (35.6) 19 (38.8) 35 (37.2) ns
Female 29 (64.4) 30 (61.2) 59 (62.8)
Age
Median 65.0 66.0 65.5 ns
IQR [53–74] [57–76] [56.0–75.8]
ASA grade
0 3 (6.7) 5 (10.2) 8 (8.5) ns
1 7 (15.6) 9 (18.4) 16 (17.0)
2 27 (60.0) 30 (61.2) 57 (60.6)
3 8 (17.8) 5 (10.2) 13 (13.8)
Smoker
Yes 25 (55.6) 30 (61.2) 55 (58.5) ns
No 20 (21.3) 19 (38.8) 39 (41.5)
BMI
Median 25.7 26.3 26.1 ns
IQR [23.8–28.6] [24.5–29.2] [24.1–28.8]
Tumour burden and pathology
Indication for surgery
Completion lymph node dissection 19 (42.2) 20 (40.8) 39 (41.4) ns
Therapeutic 26 (57.8) 29 (59.2) 55 (58.5)
Pelvic dissection
Yes 23 (51.1) 24 (49.0) 47 (50.0) ns
No 22 (48.9) 25 (51.0) 47 (50.0)
N-ratio
Median 0.20 0.16 0.17 ns
IQR [0.09–0.29] [0.11–0.20] [0.10–0.27]
Extracapsular spread
Absent 23 (51.1) 21 (42.9) 44 (46.8)
Present 10 (22.2) 11 (22.4) 21 (22.3) ns
Not stated 12 (26.7) 17 (34.7) 29 (30.9)
Perioperative course
Length of stay (days)
Median 8 8 8 ns
IQR [5.3–10.5] [6–11] [6–11]
Return to theatre
No 40 (88.9) 43 (87.8) 83 (88.3) ns
Yes 5 (11.1) 6 (12.2) 11 (11.7)
Complication (n)
No 33 (73.3) 27 (55.1) 60 (63.8) ns
Yes 12 (26.7) 22 (44.9) 34 (36.1)
Complication severitya
0 33 (35.1) 27 (28.7) 60 (63.8) ns
I 7 (7.4) 16 (17.0) 23 (24.5)
II 2 (2.1) 1 (1.1) 3 (3.2)
IIIA 0 (0.0) 0 (0.0) 0 (0.0)
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The key finding of this study was that there was a sig-
nificant association with better postoperative outcomes
(Table 1) using the 2-LNPWPT system in terms of inci-
dence of seroma formation (26.9% vs 49.4%; OR 3.0;
p\ 0.03), period of drainage (15 days vs 20 days;
p = 0.005) and return to theatre rate (0% vs 15.3%;
p = 0.03). The authors hypothesise that the dual action of
the 2-LNPWT may be the reason for these findings. The
2-LNPWT system is designed to act both as a standard
closed suction drainage system and a simultaneous com-
pression dressing. We hypothesise that the key step in
preventing the seroma is the promotion of closure and
healing of the soft tissue dead space between the flaps of
skin with subcutaneous fat and the floor of the dissected
femoral triangle. Theoretically, the compression element
acts at a pressure greater than the occlusion pressure of the
afferent lymphatic vessels in a uniform manner over the
operated area, thereby preventing the flow of lymph
through the transected vessels into the cavity. In addition
the drain removes any lymphatic fluid that would otherwise
accumulate in the cavity. Previous studies have shown that
compression dressings alone16 do not change the incidence
of seroma formation or the duration of seroma drainage. In
contrast, the clinical impact of our system was significant.
The period of postoperative drainage was reduced by
almost 1 week and the incidence of seromas was halved.
The substantial decrease in the return to theatre rate was
due to the reduced incidence of infected seromas arising in
turn from a reduction in the need for repeated needle
aspirations in the outpatient clinic.
The overall incidence of postoperative seroma was
52.9%, which was consistent with previously published
data.2 When the factors for seroma formation were anal-
ysed (Table 2), the only significant association was the
type of drainage system used (2-LNPWT 31.2% vs CSD
58.3%; p\ 0.03; OR 3.0 [1.1–8.3]). Unlike previous
studies,16 there was no association with body mass index,
age, gender, ASA grade or smoking status. Interestingly,
the data in Table 1 shows no difference in the number of
seroma aspirations or mean seroma volume between the
two drainage systems. This data would suggest that the
optimal management of a seroma is to prevent it happening
at all. Unfortunately, the duration of seroma formation
(from clinical identification to clinical resolution) was not
consistently recorded in our dataset, though it is clear from
Table 1 that, once a seroma was established, it was not
possible to reliably alter the clinical course of this com-
plication, regardless of the initial drainage system that was
employed postoperatively. These findings are consistent
with previous studies. Of note, one study found that the use
of sclerosants to reduce the clinical course of postoperative
seromas paradoxically increased the duration of the drai-
nage period.16 One conclusion that could be drawn from
this data is that the outcome of seroma formation should,
perhaps, be regarded as a common sequela to the procedure
rather than a complication. According to Dindo and Cla-
vien,17 a complication is defined as, ‘‘…any deviation from
the normal postoperative course,’’ whereas a sequela is
defined as, ‘‘…an after-effect’’ of surgery that is inherent to
the procedure. The data in this study shows that incidence
of seroma formation, though common, can be modified by
postoperative interventions, such as 2-LNPWT. Encour-
agingly, the data also shows that a seroma was not
associated with a significant increase in other complica-
tions, when managed at our unit.
The use of vacuum-assisted closure therapy is generally
considered a contraindication for wounds in the presence of
malignancy because there are theoretical concerns that it
may promote tumorigenesis and secondary metastasis by
the induction of angiogenesis in the wound bed.18 When
the disease outcomes were analysed for this cohort, the
data demonstrated that the use of the 2-LNPWT is not
associated with a worse disease-specific or overall survival,
which would suggest that it is safe to use in patients after
TABLE 2 continued
Variable No seroma formation
n = 45 (%)
Seroma formation
n = 49 (%)
Total Significance
IIIB 3 (3.2) 5 (4.3) 8 (8.5)
Drainage system
2-LNPWT 15 (68.8) 7 (31.2) 22 p\ 0.03
CSD 30 (41.7) 42 (58.3) 72 OR 3.0 (1.1–8.3)
Total 45 (47.9) 49 (52.1) 94
Period with drain (days)
Median 17 18 17 ns
IQR [9.5–15.8] [15.8–26.3] [15.0–25.0]
aThe Clavien–Dindo9 classification of surgical complications
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melanoma lymphadenectomy. Indeed, Fig. 2 demonstrates
a (non-significant) improved survival in favour of the
2-LNPWT, though this is highly likely to be due to the
significant younger age bias in this cohort (Table 1), rather
than any direct benefit from the drainage system per se.
The design of the 2-LNPWT included a non-adhesive
dressing around the foam wick inserted into the wound,
which was a deliberate ploy to prevent granulation tissue
and premature wound closure at the drainage apertures.
Accordingly, the theoretical risk of promoting tumorigen-
esis through neo-angiogenesis was reduced to a minimum.
Similar data is emerging that suggests that the use of
negative pressure wound therapy in other tumour sites can
be safely achieved in carefully selected patients.18–20
There are potential limitations and biases in this study
that merit comment. First, there was a lack of randomisa-
tion of drainage systems applied to the patients, in addition
to a lack of randomisation of drainage techniques applied
by the two surgeons in this study. Whilst the proportion of
patients undergoing completion lymph node dissection was
greater in the 2-LNPWT (61.5% vs 40.0%) and the
proportion of pelvic dissections was less (34.6% vs 56.5%),
neither differences were statistically significant and, over-
all, the similarity of the case-mix between the two cohorts
(Table 1) suggests a lack of bias in this regard. It is pos-
sible that the significant outcome differences observed may
be due to surgical technique, though this is unlikely given
that the surgeons use the same technique to perform
inguinal lymphadenectomy and had similar training (both
in the UK & Australia). Second, patients in the CSD group
did not routinely attend outpatient clinics in a prescribed
manner when compared to the 2-LNPWT cohort, who
required a visit every 3–4 days to replace the complex
dressing. Furthermore, the oversight of the drain removal
in the CSD cohort was delegated to the plastic surgery
nursing staff and the duty resident in the department. The
reasons for drain removal were not always recorded and
some drains may have been removed prematurely for fear
of ascending infection that may ultimately have been
unfounded. These potential biases may account in some
way for the differences in complications and seroma rates
observed between the two groups. Third, we did not
investigate the incidence of lymphoedema in this cohort,
therefore we cannot comment on the association of the two
systems with this particular outcome. However, studies
have shown an associated increase in lymphoedema with
postoperative surgical site infection.10,15 It is advocated
that any future randomised study should include lym-
phoedema as an endpoint. Finally, it is worth commenting
that the median length of stay was 8 days for both cohorts.
This could be considered excessive in a modern surgical
practice and the authors would not disagree with this
contention. The protocol for the management of the drains
and the hospital discharge was changed mid-way through
the audit cycle and it is now uncommon for patients to
remain as an in-patient beyond 2 days in our service,
regardless of the drainage system used. Accordingly, it is
unlikely that this contributed to any biases in this study.
CONCLUSION
This retrospective non-randomised case control study
has demonstrated the safe use of a novel application of
negative pressure wound therapy that substantially
improves the incidence of seroma formation and postop-
erative complication rate for inguinal lymphadenectomy
for melanoma. This data could possibly be extrapolated for
other disease indications requiring inguinal lymphadenec-
tomy, though we would advise caution. However, given the
encouraging data we would recommend that a prospective
phase III RCT is undertaken to validate our findings.
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FIG. 2 Kaplan–Meier curves showing disease-specific and overall
survival between the CSD and 2-LNPWT groups
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to invest in product design to improve the facility for
applying and changing the dressings in both the hospital
and primary care settings.
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